- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03185676
Efficacy of a Bilberry-based Probiotic Product on Glucose Tolerance and Insulin Resistance
February 7, 2018 updated by: Åsa Håkansson, Lund University
The Long Term Efficacy of a Bilberry-based Probiotic Product on Glucose Tolerance and Insulin Resistance as Compared to a Control.
The impact of a bilberry-based probiotic drink on the postprandial levels of serum glucose and insulin have already been study in the past.
The aim of the current study is to evaluate the long term effect of the probiotic bilberry drink on glucose tolerance and insulin resistance in healthy adults and in comparison to a control drink.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Lund, Sweden
- Klinisk Prövningsenhet, Kliniska Studier Sverige - Forum Söder
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Healthy adults with a BMI between 20-30
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Billberry
A bilberry-based probiotic beverage
|
A bilberry based probiotic beverage
|
|
ACTIVE_COMPARATOR: Control
A control beverage without bilberries or probiotics
|
A control beverage without bilberries or probiotics
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The long term effect of a bilberry-based probiotic beverage on postprandial levels of serum insulin
Time Frame: Incremental area under the curve for serum insulin from 0 min up to 120 min following the ingestion of the study product
|
The incremental area under the curve (AUC) will be measured for the levels of postprandial serum insuling from 0 min to 120 min following ingestion of the product (included intermediate measuring time points are 30, 60 and 90 min)
|
Incremental area under the curve for serum insulin from 0 min up to 120 min following the ingestion of the study product
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
May 2, 2017
Primary Completion (ACTUAL)
July 15, 2017
Study Completion (ACTUAL)
November 30, 2017
Study Registration Dates
First Submitted
June 12, 2017
First Submitted That Met QC Criteria
June 12, 2017
First Posted (ACTUAL)
June 14, 2017
Study Record Updates
Last Update Posted (ACTUAL)
February 8, 2018
Last Update Submitted That Met QC Criteria
February 7, 2018
Last Verified
February 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- InVeg (2)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insulin Resistance
-
Washington University School of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedEndoplasmic Reticulum Stress | HIV Related Insulin Resistance | Protease Inhibitor Related Insulin ResistanceUnited States
-
German Diabetes CenterYale UniversityRecruiting
-
National Institute of Diabetes and Digestive and...Active, not recruitingSevere Insulin ResistanceUnited States
-
Paloma Almeda-ValdésCompleted
-
Société des Produits Nestlé (SPN)CompletedInsulin Sensitivity/ResistanceSwitzerland
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
National Taiwan UniversityNational Cheng-Kung University HospitalCompletedExercise, Insulin Resistance, Visceral Adipose TissueTaiwan
-
University of CopenhagenNovo Nordisk A/S; Queen Mary University of London; University of SydneyNot yet recruitingInsulin Sensitivity/Resistance | Metabolic HealthDenmark
-
Assiut UniversityCompleted
-
University Health Network, TorontoCompletedInsulin Resistance Syndrome X | Pancreatic Beta Cell FunctionCanada
Clinical Trials on Bilberry
-
University of AberdeenCompletedType 2 DiabetesUnited Kingdom
-
Ole Frobert, MD, PhDOdense University Hospital; Aarhus University Hospital; Vastra Gotaland Region; Värmland County Council, Sweden and other collaboratorsActive, not recruitingMyocardial InfarctionDenmark, Sweden
-
Ullevaal University HospitalUniversity of OsloUnknownMemory | Gene ExpressionNorway
-
Region Örebro CountyCompletedMyocardial InfarctionSweden
-
Chung Shan Medical UniversityGlory Kingdom CorporationCompleted
-
Lund UniversityCompletedPostprandial Hyperglycemia
-
Marjukka KolehmainenVTT Technical Research Centre, FinlandCompletedMetabolic Syndrome | Dyslipidemia | Impaired Glucose Tolerance | Low-grade InflammationFinland
-
University of Wisconsin, MadisonCompleted
-
Applied Science & Performance InstituteCompletedCognitive Change | Mood Change | Mental ProcessesUnited States
-
University of Puerto RicoUnknown